LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

Increased expression of Fz5 receptor matched with a decrease in NeuN immunoreactivity at 16w. by Carlos González-Fernández (2794207)

Top 50 genes whose expression is most decreased in PN11 <i>Klf5</i>CN compared with the WT corneas. by Doreswamy Kenchegowda (135193)

Top 50 genes whose expression is most decreased in PN56 <i>Klf5</i>CN compared with the WT corneas. by Doreswamy Kenchegowda (135193)

Cooperativity decreases with the expression level of CheA. by Stephan Eismann (835052)

(A) Decreasing CaMKII activity by KN-93 (high-3 µmol/L, low-0.5 µmol/L), AIP (high-10 µmol/L, low-2 µmol/L), or decreasing calmodulin activity by W-7 (high-50 µmol/L, low-20 µmol/L) decreases spontaneous AP firing rate (n = 10 for each drug), cAMP (n = 4 for each drug) and ATP (n = 5 for each drug). by Yael Yaniv (162548)

– Decreasing rank differences in the comparison Wt-t0b vs Wt-t0a are plotted (in blue) against the rank of Wt-t0a and decreasing rank differences in the comparison Wt-t0a vs Wt-t0b... by Dietmar E Martin (5143)

WT1 mRNA and protein levels are decreased by GnRH. by Debalina Bagchi (686046)

Decreased FOXP3 Treg induction in LAG-3 KO cells <i>in vitro</i>. by Nicholas M. Durham (174371)

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

H-MSCs^WT decrease myofibroblasts in peri-infarction region. by Panpan Chen (307628)

ATXN3 depletion decreases PNKP’s 3’-phosphatase activity. by Arpita Chatterjee (529752)

AAV-mediated Atp6v1c1 knockdown decreased TRAP positive cells and Atp6v1c1 expression in the periodontitis lesion area. by Sheng Li (107261)

Inhibition of Rab5 Activity Decreases Fluid-Phase Uptake by Carsten Schnatwinkel (48)

Decrease in GABA in APP mice. by Ksenia V. Kastanenka (3692380)

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”

WT1 (+KTS) decreases basal and GnRH-stimulated LHβ promoter activity. by Debalina Bagchi (686046)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”

Average changes in (A) spontaneous AP firing rate, (B) ATP and (C) cAMP by decreasing CaMKII activity with KN-93 (high-3 µmol/L, low-0.5 µmol/L), AIP (high-10 µmol/L, low-2 µmol/L), or decreasing calmodulin activity by W-7 (high-50 µmol/L, low-20 µmol/L). by Yael Yaniv (162548)

EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

“…Arrows indicate lesion site. Scale bars in A–D, G,H, 100 µm; E,F, 50 µm.</p>…”